mPep1

General Information


DRACP ID  DRACP00195

Peptide Name   mPep1

Sequence  RKAFRWAWRMLKKAAPSITCVR

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Bovine lactoferrin (Lf-B)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia Leukemia IC50=8 µM MTS assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  mPep1 causes necrotic cell death by destroying cellular membrane structure

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00195

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C122H199N39O25S2

Absent amino acids  DEGHNQY

Common amino acids  AR

Mass  305104

Pl  12.52

Basic residues  7

Acidic residues  0

Hydrophobic residues  10

Net charge  7

Boman Index  -4991

Hydrophobicity  -35

Aliphatic Index  66.82

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  11000

Absorbance 280nm  523.81

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18425992

Title  A lactoferrin-derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL-61)

Doi 10.1002/psc.1039

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.